secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K
Filed at:   2024-06-18T23:59:59+00:00
Accession:  0001193125-24-163395
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lyra stockholders approve officer exculpation amendment and elect two Class I directors
--------------------------------------------------------------------------------

- Officer exculpation amendment approved: 38.8M for, 1.2M against, 8k abstain.
- Class I directors elected: Poukalov (38.6M for) and Snyderman (33.4M for).
- BDO USA ratified as auditor for FY2024: 47.5M for, 47.7k against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000119312524163395/0001193125-24-163395-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000119312524163395/d614069d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-163395

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer